Literature DB >> 13613503

Lupus erythematosus treated with a combination of quinacrine, hydroxychloroquine and chloroquine.

M J TYE, H WHITE, B APPEL, H B ANSELL.   

Abstract

Entities:  

Keywords:  CHLOROQUINE/therapeutic use; LUPUS ERYTHEMATOSUS, DISCOID/therapy; LUPUS ERYTHEMATOSUS, DISSEMINATED/therapy; QUINACRINE/therapeutic use

Mesh：

Substances：

Year:  1959        PMID： 13613503     DOI： 10.1056/NEJM195901082600203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Safia Ogbi; Takayuki Matsumoto; R Clinton Webb
Journal:  Pharmacol Res       Date:  2016-09-14       Impact factor: 7.658

2.  Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Sara Kaprove Penn; Amy H Kao; Laura L Schott; Jennifer R Elliott; Frederico G S Toledo; Lewis Kuller; Susan Manzi; Mary Chester M Wasko
Journal:  J Rheumatol       Date:  2010-05-01       Impact factor: 4.666

Review 3.  The evolution of drug discovery in systemic lupus erythematosus.

Authors:  Daniel J Wallace
Journal:  Nat Rev Rheumatol       Date:  2015-06-30       Impact factor: 20.543

4.  Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.

Authors:  Jacob H Rand; Xiao-Xuan Wu; Anthony S Quinn; Anthony W Ashton; Pojen P Chen; James J Hathcock; Harry A M Andree; Douglas J Taatjes
Journal:  Blood       Date:  2009-11-30       Impact factor: 22.113

5.  Chloroquine Suppresses the Development of Hypertension in Spontaneously Hypertensive Rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Babak Baban; Takayuki Matsumoto; R Clinton Webb
Journal:  Am J Hypertens       Date:  2016-09-13       Impact factor: 2.689

Review 6.  Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.

Authors:  Domenico Plantone; Tatiana Koudriavtseva
Journal:  Clin Drug Investig       Date:  2018-08       Impact factor: 3.580

7.  Association of Higher Hydroxychloroquine Blood Levels With Reduced Thrombosis Risk in Systemic Lupus Erythematosus.

Authors:  Michelle Petri; Maximilian F Konig; Jessica Li; Daniel W Goldman
Journal:  Arthritis Rheumatol       Date:  2021-05-02       Impact factor: 15.483

Review 8.  A highlight from the LUPUS 2014 meeting: eight great ideas.

Authors:  Jill P Buyon; Phillip Cohen; Joan T Merrill; Gary Gilkeson; Mariana Kaplan; Judith James; W Joseph McCune; Sasha Bernatsky; Keith Elkon
Journal:  Lupus Sci Med       Date:  2015-06-30

9.  Looking for the best anti-colitis medicine: A comparative analysis of current and prospective compounds.

Authors:  Anastasiya A Chumanevich; Anusha Chaparala; Erin E Witalison; Hossam Tashkandi; Anne B Hofseth; Corey Lane; Edsel Pena; Piaomu Liu; Doug L Pittman; Prakash Nagarkatti; Mitzi Nagarkatti; Lorne J Hofseth; Alexander A Chumanevich
Journal:  Oncotarget       Date:  2017-01-03

Review 10.  Toll-like receptors in systemic autoimmune disease.

Authors:  Ann Marshak-Rothstein
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.